Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Gent DG, Rivera-Caravaca JM, Dobson R, Wright DJ, Lip GYH; Liverpool Centre for Cardiovascular Science. Ibrutinib use and adverse cardiovascular outcomes: A United States federated electronic medical records analysis. Eur J Intern Med. 2023 Feb;108:117-119. doi: 10.1016/j.ejim.2022.09.016. Epub 2022 Sep 24. No abstract available. PubMed PMID: 36163123.
AÑO: 2023; IF: 8.0
McEwan P, Harrison C, Binnie R, Lewis RD, Cohen-Solal A, Lund LH, Ohlsson M, von Haehling S, Comin-Colet J, Pascual-Figal DA, Wachter S, Dorigotti F, de Arellano AR, Ponikowski P, Jankowska EA. Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalisation: A European multinational economic evaluation. Eur J Heart Fail. 2023 Jan 31. doi: 10.1002/ejhf.2788. Online ahead of print. PubMed PMID: 36718652.
AÑO: 2023; IF: 18.2
Diego-Nieto A, Nunez JC, Minana G, Amat-Santos IJ, Salinas-Sanguino P, Mohandes M, Regueiro A, Pan M, Lacunza J, Caballero-Borrego J, Fernandez-Diaz JA, Fernandez Cisnal A, Santos-Martinez S, Gonzalo N, Vaquerizo B, Rivero F, Jurado-Roman A, Abellan-Huerta J, Rumiz Gonzalez E, Rondan-Murillo J, Lopez Benito M, Astorga Burgo JC, Jimenez Mazuecos J, Bosa Ojeda F, Moreno-Ambroj C, Sabate M, Ojeda S, Valdesuso Aguilar R, Lopez Perez M, Sanchis J, Campo-Prieto A, Escaned J, Goicolea J, Martin-Moreiras J. Safety and feasibility of transradial access for percutaneous coronary intervention in chronic total occlusions. Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):253-260. doi: 10.1016/j.rec.2022.05.019. Epub 2022 Jun 9. English, Spanish. PubMed PMID: 35691552.
AÑO: 2023; IF: 5.9
Parisi V, Baldassarre R, Ferrara V, Ditaranto R, Barlocco F, Lillo R, Re F, Marchi G, Chiti C, Di Nicola F, Catalano C, Barile L, Schiavo MA, Ponziani A, Saturi G, Caponetti AG, Berardini A, Graziosi M, Pasquale F, Salamon I, Ferracin M, Nardi E, Capelli I, Girelli D, Gimeno Blanes JR, Biffi M, Galie N, Olivotto I, Graziani F, Biagini E. Electrocardiogram analysis in Anderson-Fabry disease: a valuable tool for progressive phenotypic expression tracking. Front Cardiovasc Med. 2023 Jun 21;10:1184361. doi: 10.3389/fcvm.2023.1184361. eCollection 2023. PubMed PMID: 37416917; PubMed Central PMCID: PMC10320218.
AÑO: 2023; IF: 3.6
Soler-Espejo E, Esteve-Pastor MA, Rivera-Caravaca JM, Roldan V, Marin F. Reducing bleeding risk in patients on oral anticoagulation therapy. Expert Rev Cardiovasc Ther. 2023 Oct 31:1-14. doi: 10.1080/14779072.2023.2275662. Online ahead of print. PubMed PMID: 37905915.
AÑO: 2023; IF: 2.0
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII